Daré Bioscience, Inc. develops therapies in the areas of contraception, fertility, and sexual and vaginal health.Its product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its products in advanced clinical development include Ovaprene, a hormone-free monthly vaginal contraceptive.
